|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 356.05 INR | +0.84% |
|
-1.53% | -13.80% |
| 07/03 | Pinnacle Life Science Pvt. Ltd announced that it expects to receive INR 100 million in funding from Aarti Drugs Limited | CI |
| 04/02 | Aarti Drugs Limited, Q3 2026 Earnings Call, Feb 04, 2026 |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Medicinal Chemicals and Botanical Products | ||||||||||
Pharmaceuticals | 2.15TCr | 2.49TCr | 2.72TCr | 2.53TCr | 2.39TCr | |||||
Total Assets | 1.77TCr | 2.21TCr | 2.42TCr | 2.43TCr | 2.57TCr | |||||
Interest Expense | -23Cr | -21Cr | -33Cr | -34Cr | -36Cr | |||||
Income Tax Expense | 89Cr | 65Cr | 58Cr | 64Cr | 44Cr | |||||
CAPEX | -88Cr | -151.97Cr | -164.82Cr | -226.33Cr | -177.16Cr | |||||
EBT | 369.01Cr | 269.96Cr | 224.18Cr | 235.53Cr | 211.77Cr | |||||
D&A | 49Cr | 50Cr | 50Cr | 51Cr | 54Cr | |||||
Operating Income | - | - | - | - | - | |||||
Net Income | 280.41Cr | 205.04Cr | 166.31Cr | 171.42Cr | 168.16Cr |
Geographical Revenue Distribution History
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
India | 1.38TCr | 1.57TCr | 1.64TCr | 1.67TCr | 1.52TCr | |||||
Out of India | 773.23Cr | 922.33Cr | 1.07TCr | 862.88Cr | 865.33Cr |
- Stock Market
- Equities
- AARTIDRUGS Stock
- Financials Aarti Drugs Limited
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition